Thursday - March 12, 2026

Category Archives: Marketing & Sales

Peripheral T-Cell Lymphoma Market Outlook 2034: US Market Surpasses USD 500 Million in 2023 with 12,600+ Cases Driving Demand for Next-Gen Treatments, analyses DelveInsight

Peripheral T-Cell Lymphoma Market Leading companies developing Peripheral T-cell Lymphoma treatments include Eisai, Celgene Corporation, HUYA Bioscience International/Quintiles, Verastem, BeiGene, Merck Sharp & Dohme Corp, Solasia Pharma, Aileron Therapeutics, Incyte, Novartis, among others. In 2023, the US led the Peripheral … Continue reading →

Psoriatic Arthritis Market Outlook 2034: 30+ Key Companies, 20+ Emerging Drugs, and Expanding 7MM Epidemiology Insights | DelveInsight

Psoriatic Arthritis Market Psoriatic Arthritis companies are UCB Biopharma, Sun Pharmaceutical Industries Limited, BMS, Affibody AB, Janssen Biotech, Amgen, Eli Lilly and Company, Teva Pharma, Boehringer Ingelheim, AbbVie, Roche, Ampio Pharmaceuticals, Antares Pharma, Currax Pharmaceuticals, GlaxoSmithKline, Bayer, Sanofi, Astrazeneca, Johnson … Continue reading →

Psychosis in Parkinson’s and Alzheimer’s Disease Market to Surpass USD 1.29 Billion by 2034 Across the 7MM, 6.9 Million Psychosis Cases and 5+ Emerging Therapies Driving Growth, analyses DelveInsight

Psychosis in Parkinson’s and Alzheimer’s Disease Market Key Psychosis in Parkinson’s and Alzheimer’s Disease Companies are Karuna Therapeutics, Sunovion Pharmaceuticals, Intra-Cellular Therapies, Acadia Pharmaceuticals, and others DelveInsight has launched a new report on “Psychosis in Parkinson’s and Alzheimer’s Disease – … Continue reading →

Peripheral Nerve Injuries Market: Growth Momentum Across 7MM to 2034 – DelveInsight | Orthocell, Neuraptive Therapeutics, Samyang Biopharmaceuticals

The Key Peripheral Nerve Injuries Companies in the market inlcude – Axogen Corporation, Toyobo, KLISBio, Orthocell Limited, Orthocell, Neuraptive Therapeutics, Samyang Biopharmaceuticals, Astellas Pharma Inc, and others.   DelveInsight’s “Peripheral Nerve Injuries Market Insights, Epidemiology, and Market Forecast-2034″ report offers … Continue reading →

Myasthenia Gravis Market: Pharma Pipeline Fuels Rapid Expansion by 2034 – DelveInsight | Sanofi, Cartesian Therapeutics, Takeda, UCB Biopharma, Hoffmann-La Roche, Janssen Research & Development, LLC

The Key Myasthenia Gravis Companies in the marke include – Alexion, AstraZeneca, Argenx, Novartis, Alpine Immune Science, Toleranzia, Cabaletta Bio, Rallybio, Alexion Pharmaceuticals, Takeda, Cartesian Therapeutics, RemeGen, Horizon Therapeutics, and others.   DelveInsight’s “Myasthenia Gravis Market Insights, Epidemiology, and Market … Continue reading →

Projecting the Global Stress Urinary Incontinence Devices Market to Expand at a 6.53% CAGR Through 2034, DelveInsight Analysis

Stress Urinary Incontinence Devices Market Insights, Competitive Landscape, and Market Forecast – 2034” report provides the current and forecast market outlook, forthcoming device innovation, challenges, market drivers and barriers.   As per DelveInsight’s assessment, The stress urinary incontinence devices market … Continue reading →

Latin Launch Expands Meta Ads Management Services to Help Vancouver Businesses Grow on Facebook and Instagram

VANCOUVER, BC – Latin Launch expands its Meta ads management services for businesses across Metro Vancouver, offering structured Facebook and Instagram advertising solutions designed to reach the right audiences, generate qualified leads, and support business growth. As Meta’s advertising platform continues … Continue reading →

Fabry Disease Market: Rapid Growth & Investment Outlook to 2034 – DelveInsight | Sanofi Genzyme, Sangamo Therapeutics, Freeline Therapeutics, AVROBIO, 4D Molecular Therapeutics

The Key Fabry Disease Companies in the market include – Chiesi and Protalix Biotherapeutics, Sanofi Genzyme, Sangamo Therapeutics, Protalix Biotherapeutics, AVROBIO, Sanofi Genzyme, Sangamo Therapeutics, Freeline Therapeutics, 4D Molecular Therapeutics, Idorsia Pharmaceuticals, Greenovation Biotech GMBH, ICON plc, Chiesi Farmaceutici S.p.A., … Continue reading →